COMPANY

Lexicon Pharmaceuticals

Keywords: chronic pain

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $55.67M (Form D filed Feb 17, 2026). SEC Form D 0001193125-26-054545 (Feb 17, 2026)
Evidence (1 event)
- Feb 17, 2026 · SEC Form D 0001193125-26-054545
  Name of Issuer: LEXICON PHARMACEUTICALS, INC.; CIK: 1062822; Address: The Woodlands, TX; Submission type: D; Filing date: 2026-02-17; Industry Group: Pharmaceuticals; Date of First Sale: 2026-02-02; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 59150000; Total Amount Sold: 55668255; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

May 4, 2026 Debt Debt: $100M (not counted as a raise), announced May 4, 2026. Source: SEC filing. source ↗

Debt: $100.0M. Last 2 years.

May 4, 2026 Debt: $100M (not counted as a raise), announced May 4, 2026. Source: SEC filing. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2026-02-17 Raise Private raise (SEC Form D): $55.7M sold of $59.1M offered; issuer “LEXICON PHARMACEUTICALS, INC.”. Verified from the SEC filing. SEC filing ↗